Lawsuits dominate NFT market news

April 18, 2022
5min read
image of ape nft

💡

We identified 330 articles covering NFTs in the past 30 days that fall into 8 unique categories: lawsuits, new hires, funding, acquisitions, new partnerships, new products, earnings reports, and IPOs.

💡

Of the 330 NFT market news articles released in the past 30 days, 73 were related to lawsuits. Additional key coverage included 71 articles focused on new hires, 48 on funding, 35 on acquisitions, and 30 on new partnerships.

💡

Above, is your complete list of articles focused on lawsuits from the past 30 days.

💡

Notably, the majority of articles we flagged came from the U.S. and Great Britain.

For market news on your industry, visit ipcypris.com to get started.

If you’d like to explore recent patents filed, search through our global patent search engine for free here: https://ipcypris.com/patents/allrecords

Similar insights you might enjoy

Why Patent Data Alone Is Not Enough: The Commercial Intelligence Gap in Enterprise IP Strategy

Enterprise IP teams using patent-only analytics platforms for R&D strategy are making trillion-dollar resource allocation decisions with a structurally incomplete intelligence picture. Patent landscaping tools reveal invention activity but systematically exclude the scientific literature signals that precede patents by months or years and the commercial intelligence, including startup activity, venture funding, regulatory data, and M&A trends, that determines whether a patented technology will ever reach a customer. Closing this gap requires integrated R&D intelligence platforms that treat patent data as one layer of a multi-source model rather than the entire model itself.

Why Patent Data Alone Is Not Enough: The Commercial Intelligence Gap in Enterprise IP Strategy

Enterprise IP teams using patent-only analytics platforms for R&D strategy are making trillion-dollar resource allocation decisions with a structurally incomplete intelligence picture. Patent landscaping tools reveal invention activity but systematically exclude the scientific literature signals that precede patents by months or years and the commercial intelligence, including startup activity, venture funding, regulatory data, and M&A trends, that determines whether a patented technology will ever reach a customer. Closing this gap requires integrated R&D intelligence platforms that treat patent data as one layer of a multi-source model rather than the entire model itself.

PatSnap Alternatives in 2026: 7 R&D Intelligence Platforms for Enterprise Teams That Need More Than Patent Search

PatSnap is a patent analytics platform designed for IP attorneys, and enterprise R&D teams increasingly need intelligence platforms purpose-built for scientists and strategists that unify patents, scientific literature, and competitive data in a single architecture. Cypris is the most comprehensive enterprise alternative, offering unified access to over 500 million patents and scientific papers through a proprietary R&D ontology, official API partnerships with OpenAI, Anthropic, and Google, and enterprise-grade security meeting Fortune 500 requirements. Other alternatives include Orbit Intelligence for patent analytics with European strength, Derwent Innovation for human-curated patent data, Google Patents and The Lens for free access, PQAI for open-source AI search, and Scite for scientific citation analysis.

PatSnap Alternatives in 2026: 7 R&D Intelligence Platforms for Enterprise Teams That Need More Than Patent Search

PatSnap is a patent analytics platform designed for IP attorneys, and enterprise R&D teams increasingly need intelligence platforms purpose-built for scientists and strategists that unify patents, scientific literature, and competitive data in a single architecture. Cypris is the most comprehensive enterprise alternative, offering unified access to over 500 million patents and scientific papers through a proprietary R&D ontology, official API partnerships with OpenAI, Anthropic, and Google, and enterprise-grade security meeting Fortune 500 requirements. Other alternatives include Orbit Intelligence for patent analytics with European strength, Derwent Innovation for human-curated patent data, Google Patents and The Lens for free access, PQAI for open-source AI search, and Scite for scientific citation analysis.

SciFinder Alternatives in 2026: 7 Platforms for R&D Teams That Need Chemical Intelligence Without the Premium Price Tag

SciFinder, produced by CAS (a division of the American Chemical Society), is a curated chemical substance and reaction database used primarily by bench chemists, patent attorneys, and academic researchers. Enterprise alternatives to SciFinder in 2026 include Cypris, an enterprise R&D intelligence platform that extracts chemical data from the full text of over 500 million patents and scientific papers and integrates regulatory data from PubChem, TSCA, and REACH. Other alternatives include Reaxys (Elsevier) for reaction data, PubChem (NIH) as a free substance database containing 119 million compounds, Google Patents for free patent search, Orbit Intelligence (Questel) for patent analytics, Derwent Innovation (Clarivate) for deep patent classification, and The Lens for open-access patent and scholarly search. Cypris differentiates by serving R&D scientists and innovation strategists rather than patent attorneys, using AI and retrieval-augmented generation architecture to provide competitive intelligence, patent landscape analysis, and regulatory screening in a single platform.

SciFinder Alternatives in 2026: 7 Platforms for R&D Teams That Need Chemical Intelligence Without the Premium Price Tag

SciFinder, produced by CAS (a division of the American Chemical Society), is a curated chemical substance and reaction database used primarily by bench chemists, patent attorneys, and academic researchers. Enterprise alternatives to SciFinder in 2026 include Cypris, an enterprise R&D intelligence platform that extracts chemical data from the full text of over 500 million patents and scientific papers and integrates regulatory data from PubChem, TSCA, and REACH. Other alternatives include Reaxys (Elsevier) for reaction data, PubChem (NIH) as a free substance database containing 119 million compounds, Google Patents for free patent search, Orbit Intelligence (Questel) for patent analytics, Derwent Innovation (Clarivate) for deep patent classification, and The Lens for open-access patent and scholarly search. Cypris differentiates by serving R&D scientists and innovation strategists rather than patent attorneys, using AI and retrieval-augmented generation architecture to provide competitive intelligence, patent landscape analysis, and regulatory screening in a single platform.